Although the exact mechanism by which Chk1 inhibitors sensitize cancer cells to radiation is not yet fully understood, it is believed that Chk1 inhibition leads to the accumulation of DNA damage, which in turn enhances the efficacy of radiation therapy. Here, CHEK1 is linked to cancer.